Deltyba is available from Insulinhub.
Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine
According to the European Medicines Agency, brand name Deltyba originating from Europe is manufactured at the following site(s):Otsuka Novel Products GmbH Erika-Mann-Straße 21 80636 München Germany R-Pharm Germany GmbH Heinrich-Mack-Straße 35 89257 Illertissen Germany
Information about Deltyba (Delamanid)
Deltyba is a prescription medication used in the treatment of multidrug-resistant tuberculosis (MDR-TB). It is specifically designed to work against strains of Mycobacterium tuberculosis that are resistant to first-line anti-TB drugs.
Product Highlights
- Deltyba is indicated for use in combination with other appropriate anti-tuberculosis drugs for the treatment of pulmonary MDR-TB in adults and children aged 6 years and older.
Key Ingredient
Key Benefits
- Targets strains of tuberculosis resistant to first-line treatments.
- Delamanid inhibits the synthesis of mycolic acids, which are essential components of the bacterial cell wall.
- In combination with other anti-TB drugs, it enhances the efficacy of MDR-TB treatment regimens.
Direction of Use
- Typically, the recommended dosage is 100 mg twice daily for adults and children weighing 30 kg or more. For children weighing less than 30 kg, the dosage should be adjusted based on body weight and clinical judgment.
- Take Deltyba orally with or without food. Take the tablets whole; avoid chewing or crushing them.
Safety Concerns
- Nausea, vomiting, and diarrhea may occur. Monitor for signs of hepatotoxicity, as liver enzyme elevations can occur.
- Regular monitoring of liver function is recommended during treatment.
- May interact with other medications, so inform your healthcare provider of all drugs you are taking.
Avoid Deltyba (Delamanid) If
- You have a known hypersensitivity to Delamanid or any of its components.
- Deltyba should be used cautiously or avoided in patients with severe hepatic impairment.
- The safety of Deltyba during pregnancy and breastfeeding has not been established. Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
